Detalhe da pesquisa
1.
Author Correction: ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection.
Nat Immunol
; 21(10): 1302, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32855556
2.
ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection.
Nat Immunol
; 21(10): 1293-1301, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32807944
3.
Postmortem Stability of SARS-CoV-2 in Mouse Lung Tissue.
Emerg Infect Dis
; 27(12): 3173-3175, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34559046
4.
Serologic Responses in Healthy Adult with SARS-CoV-2 Reinfection, Hong Kong, August 2020.
Emerg Infect Dis
; 26(12): 3076-3078, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33089772
5.
Serological assays for differentiating natural COVID-19 infection from vaccine induced immunity.
J Clin Virol
; 170: 105621, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38056114
6.
Usp25-Erlin1/2 activity limits cholesterol flux to restrict virus infection.
Dev Cell
; 58(22): 2495-2509.e6, 2023 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37683630
7.
Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population.
Nat Med
; 29(2): 348-357, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652990
8.
SARS-CoV-2 accessory proteins reveal distinct serological signatures in children.
Nat Commun
; 13(1): 2951, 2022 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35618731
9.
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents.
Nat Commun
; 13(1): 3700, 2022 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35764637
10.
Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targets.
Curr Opin Virol
; 50: 139-146, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34464844
11.
Repeated influenza vaccination provides cumulative protection from distinct H3N2 viruses.
Clin Transl Immunology
; 10(6): e1297, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34136219
12.
T Cells Targeting SARS-CoV-2: By Infection, Vaccination, and Against Future Variants.
Front Med (Lausanne)
; 8: 793102, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35004764
13.
The SARS-CoV-2 antibody landscape is lower in magnitude for structural proteins, diversified for accessory proteins and stable long-term in children.
medRxiv
; 2021 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33655259
14.
SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection.
Nat Commun
; 12(1): 4678, 2021 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34326343
15.
Domain-specific biochemical and serological characterization of SARS-CoV-2 nucleocapsid protein.
STAR Protoc
; 2(4): 100906, 2021 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34642671
16.
Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain.
iScience
; 24(6): 102681, 2021 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34095780
17.
SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection.
medRxiv
; 2021 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33564773
18.
Vaccination with ADCC activating HA peptide epitopes provides partial protection from influenza infection.
Vaccine
; 38(37): 5885-5890, 2020 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32718818
19.
Assessment of enhanced influenza vaccination finds that FluAd conveys an advantage in mice and older adults.
Clin Transl Immunology
; 9(2): e1107, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32025302
20.
Characterization of SARS-CoV-2 N protein reveals multiple functional consequences of the C-terminal domain.
bioRxiv
; 2020 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33269347